Publications

Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials

Chan XHS. et al, (2024), The Lancet Microbe, 101002 - 101002

Autochthonous Human Babesia divergens Infection, England

Zabala GA. et al, (2024), Emerging Infectious Diseases, 30

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Faust SN. et al, (2024), The Lancet Child & Adolescent Health

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2023), The Lancet Diabetes & Endocrinology, 11, 905 - 914

Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis.

Meskell P. et al, (2023), The Cochrane database of systematic reviews, 9

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2023), The Lancet, 401, 1499 - 1507

Raising awareness of antimicrobial resistance: development of an ‘antibiotic footprint calculator’

Prapharsavat R. et al, (2023), Journal of Antimicrobial Chemotherapy

Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years

Imdad A. et al, (2023), Cochrane Database of Systematic Reviews, 2023

Chest radiograph classification and severity of suspected COVID-19 by different radiologist groups and attending clinicians: multi-reader, multi-case study

Nair A. et al, (2022), European Radiology

Cardiovascular Concentration‐Effect Relationships of Amodiaquine and its Metabolite Desethylamodiaquine: Clinical and Pre‐clinical Studies

Chan XHS. et al, (2022), British Journal of Clinical Pharmacology

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Abani O. et al, (2022), The Lancet, 400, 359 - 368

Reducing broad-spectrum antibiotic use in intensive care unit between first and second waves of COVID-19 did not adversely affect mortality.

Chan XHS. et al, (2022), The Journal of hospital infection, 124, 37 - 46

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2022), The Lancet, 399, 665 - 676

Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis

Meskell P. et al, (2022), Cochrane Database of Systematic Reviews, 2022

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2022), The Lancet, 399, 143 - 151

935. A Hospital Cluster of the Emerging Drug-resistant Yeast Saprochaete clavata

Chan XHS. et al, (2021), Open forum infectious diseases, 8, S560 - S560

Risk factors associated with bloodstream infections among critically ill patients with COVID-19

McMillan T. et al, (2021), Journal of Infection, 83, e1 - e3

The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis

Chan XHS. et al, (2021), PLOS Medicine, 18, e1003766 - e1003766

Performance and impact of disposable and reusable respirators for healthcare workers during pandemic respiratory disease: a rapid evidence review

Burton C. et al, (2021), Occupational and Environmental Medicine, 78, 679 - 690

Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination

Jacob CG. et al, (2021), eLife, 10

Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate

Chaudhry Z. et al, (2021), Journal of Infection, 82, 276 - 316

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2021)

The utility of an AMR dictionary as an educational tool to improve public understanding of antimicrobial resistance

Prapharsavat R. et al, (2021), Wellcome Open Research, 6, 113 - 113

Twitter Analytics to Inform Provisional Guidance for COVID-19 Challenges in the Meatpacking Industry

Durand-Moreau Q. et al, (2021), Annals of Work Exposures and Health, 65, 373 - 376

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2021), The Lancet, 397, 1637 - 1645

Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine

Whittaker DG. et al, (2021), Royal Society Open Science, 8

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2021)

Dexamethasone in Hospitalized Patients with Covid-19

(2021), New England Journal of Medicine, 384, 693 - 704

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abaleke E. et al, (2021), The Lancet, 397, 605 - 612

Barriers and facilitators to healthcare workers' adherence with infection prevention and control guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis.

Houghton C. et al, (2021), Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, 33, 62 - 64

Aortic thrombosis in COVID-19

Wickham H. et al, (2021), Clinical Infection in Practice, 9, 100059 - 100059

A QuESt for speed: rapid qualitative evidence syntheses as a response to the COVID-19 pandemic

Biesty L. et al, (2020), Systematic Reviews, 9

Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study

Imwong M. et al, (2020), The Lancet Infectious Diseases, 20, 1470 - 1480

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

(2020), New England Journal of Medicine, 383, 2030 - 2040

Classification of aerosol-generating procedures: a rapid systematic review

Jackson T. et al, (2020), BMJ Open Respiratory Research, 7, e000730 - e000730

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology

White NJ. et al, (2020), PLOS Medicine, 17, e1003252 - e1003252

Cardiopulmonary resuscitation in primary and community care during the COVID-19 pandemic

Khunti K. et al, (2020), British Journal of General Practice, 70, 374 - 375

The efficacy of PPE for COVID-19-type respiratory illnesses in primary and community care staff

Khunti K. et al, (2020), British Journal of General Practice, 70, 413 - 416

Genetic surveillance in the Greater Mekong Subregion and South Asia to support malaria control and elimination

Jacob CG. et al, (2020)

Extended use or re-use of single-use surgical masks and filtering facepiece respirators: A rapid evidence review

Toomey E. et al, (2020)

Barriers and facilitators to healthcare workers’ adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis

Houghton C. et al, (2020), Cochrane Database of Systematic Reviews, 2020

Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data

Chan XHS. et al, (2020), PLOS Medicine, 17, e1003040 - e1003040

A Temporizing Solution to “Artemisinin Resistance”

(2019), New England Journal of Medicine, 381, 989 - 990

Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study

Hamilton WL. et al, (2019), The Lancet Infectious Diseases, 19, 943 - 951

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial

von Seidlein L. et al, (2019), PLOS Medicine, 16, e1002745 - e1002745

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review

Haeusler IL. et al, (2018), BMC Medicine, 16

Risk of sudden unexplained death after use of dihydroartemisinin–piperaquine for malaria: a systematic review and Bayesian meta-analysis

Chan XHS. et al, (2018), The Lancet Infectious Diseases, 18, 913 - 923

LOW RISK OF SUDDEN UNEXPLAINED DEATH AFTER DIHYDROARTEMISININ-PIPERAQUINE: A SYSTEMATIC REVIEW AND BAYESIAN META-ANALYSIS

Chan X. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 577 - 578

Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application

Tun STT. et al, (2017), PLOS ONE, 12, e0177840 - e0177840

HIV - lessons from a late diagnosis.

Chan XHS. et al, (2016), Acute medicine, 15, 84 - 87

Cookies on this website

Publications